Recombinant phenotyping of cytomegalovirus UL97 kinase sequence variants for ganciclovir resistance.
A strain of human cytomegalovirus, T2211, modified from standard laboratory strain AD169 to contain a secreted alkaline phosphatase reporter gene for rapid viral quantitation, was cloned as a bacterial artificial chromosome, BA1, and then mutagenized to create recombinant viruses containing viral UL97 kinase sequence variants found in clinical specimens after ganciclovir treatment, but with no phenotypic data to determine their role in drug resistance. Seven control strains and 14 other recombinant strains were phenotyped for ganciclovir resistance and compared with similar strains created using prior technology to show a good concordance of findings. Sequence changes V466M, H469Y, A478V, N510S, A588V, K599R, L600I, G623S, T659I, and V665I were found to confer no significant ganciclovir resistance, while mutations L405P, M460T, A594E, and C603R conferred 3- to 9-fold increases in ganciclovir 50% inhibitory concentrations. Different mutations at codons 594 (A594V, A594E) and 603 (C603W, C603S) conferred varied amounts of ganciclovir resistance. Advances in recombinant phenotyping make it easier to show that many uncharacterized UL97 sequence variants do not confer ganciclovir resistance, but some are newly confirmed as resistance associated, including one (L405P) which is outside the codon range where such mutations are usually found. This information should improve the interpretation of genotypic data generated by diagnostic laboratories.
Chou
Sunwen
S
Division of Infectious Diseases, Oregon Health and Science University, and Department of Veterans Affairs Medical Center, Portland, Oregon, USA. chous@ohsu.edu
D000998:Antiviral Agents / Q000494:pharmacology*; D001483:Base Sequence; D022202:Chromosomes, Artificial, Bacterial / Q000235:genetics; D003001:Cloning, Molecular; D003587:Cytomegalovirus / Q000187:drug effects* / Q000201:enzymology / Q000235:genetics*; D017931:DNA Primers / Q000235:genetics; D024882:Drug Resistance, Viral / Q000235:genetics; D015774:Ganciclovir / Q000494:pharmacology*; D005814:Genes, Viral; D014644:Genetic Variation; D006801:Humans; D066298:In Vitro Techniques; D016296:Mutagenesis; D010641:Phenotype; D017853:Phosphotransferases (Alcohol Group Acceptor) / Q000235:genetics*; D011995:Recombination, Genetic
D000998:Antiviral Agents; D017931:DNA Primers; D017853:Phosphotransferases (Alcohol Group Acceptor); C075365:ganciclovir kinase; D015774:Ganciclovir
Drug Resist Updat. 2002 Apr;5(2):88-114
12135584
Lancet. 2000 Aug 19;356(9230):645-9
10968438
Science. 1988 Jul 1;241(4861):42-52
3291115
J Infect Dis. 2001 Dec 15;184(12):1598-602
11740736
J Virol. 1999 Oct;73(10):8320-9
10482582
Antiviral Res. 2002 Apr;54(1):59-67
11888658
J Clin Invest. 1995 Jan;95(1):257-63
7814623
J Infect Dis. 1997 Sep;176(3):786-9
9291334
J Infect Dis. 2001 Jan 15;183(2):333-337
11120934
J Clin Virol. 2010 Apr;47(4):321-4
20138805
Nucleic Acids Res. 2005 Feb 24;33(4):e36
15731329
Antiviral Res. 1998 Dec;40(1-2):95-103
9864050
J Virol. 1998 Jul;72(7):5927-36
9621055
Am J Transplant. 2005 Jun;5(6):1462-8
15888055
J Infect Dis. 2007 Jul 1;196(1):91-4
17538888
Rev Med Virol. 2008 Jul-Aug;18(4):233-46
18383425
J Heart Lung Transplant. 2007 Dec;26(12):1286-92
18096480
Antimicrob Agents Chemother. 2005 Jul;49(7):2710-5
15980340
J Infect Dis. 2002 Jan 15;185(2):162-9
11807689
J Infect Dis. 2002 Sep 15;186(6):760-8
12198609
J Gen Virol. 1998 Sep;79 ( Pt 9):2105-12
9747718
J Infect Dis. 1998 Aug;178(2):531-4
9697737
J Mol Biol. 1967 Jun 14;26(2):365-9
4291934
J Infect Dis. 1995 Mar;171(3):576-83
7876604
Clin Infect Dis. 1995 Oct;21 Suppl 2:S170-3
8845447
J Clin Virol. 2008 Sep;43(1):107-9
18502683
J Infect Dis. 2006 Sep 1;194(5):579-83
16897654
J Med Virol. 2009 Mar;81(3):507-10
19152402
Antimicrob Agents Chemother. 2001 Oct;45(10):2775-80
11557468
J Virol. 1994 Jul;68(7):4427-31
8207815
J Infect Dis. 1997 Jul;176(1):69-77
9207351
Rev Med Virol. 2009 Jul;19(4):215-29
19434630
Antimicrob Agents Chemother. 2005 Mar;49(3):873-83
15728878
J Clin Microbiol. 2007 Aug;45(8):2681-3
17537934
J Clin Virol. 1999 Aug;13(3):141-8
10443790